Clinical study of oral propranolol treatment for pediatric hemangioma and lymphangioma
Not Applicable
- Conditions
- pediatric hemangioma and lymphangioma
- Registration Number
- JPRN-UMIN000004453
- Lead Sponsor
- Gifu University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Heart disease and hypotension. Patient who has drug allergy, and patient with the past of serious side effect by the propranolol drug. Patient who was considered ineligible by the investigators.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of symptoms. SIde effects.
- Secondary Outcome Measures
Name Time Method